Read More

Avalon GloboCare Announces Closing Of Strategic Investment In Laboratory Services MSO, A Leading Clinical Diagnostics And Reference Laboratory Company; Total Consideration For The Transaction Was $21M

Transaction Expected to Be Accretive to Earnings Through Profit Sharing Agreement Adds Strong Clinical Synergies to Existing Avalon Portfolio Marks Launch of New Roll-Up Strategy Targeting Toxicology and

ALBT

Read More

Insulet Acquires Assets Related To Bigfoot’s Pump-based Automated Insulin Delivery Technologies For $25M, Including Certain Bigfoot Patents Related To Pumps That May Be Used For Automated Insulin Delivery Therapy

The transaction further strengthens Insulet's intellectual property (IP) portfolio and provides Bigfoot with additional capital to expand its Bigfoot Unity® Diabetes Management System to more people in need of

PODD